Pro Medicus Limited (ASX:PME – Get Free Report) insider Anthony Glenning bought 50 shares of Pro Medicus stock in a transaction that occurred on Wednesday, March 12th. The stock was purchased at an average price of A$219.58 ($138.97) per share, for a total transaction of A$10,979.00 ($6,948.73).
Pro Medicus Stock Performance
The company has a market capitalization of $29.16 billion, a P/E ratio of 351.99, a PEG ratio of 3.87 and a beta of 0.56. The company has a quick ratio of 4.39, a current ratio of 5.98 and a debt-to-equity ratio of 1.10.
Pro Medicus Increases Dividend
The business also recently disclosed a Interim dividend, which will be paid on Thursday, March 20th. Shareholders of record on Thursday, March 20th will be paid a dividend of $0.25 per share. This represents a dividend yield of 0.09%. The ex-dividend date is Wednesday, February 26th. This is a boost from Pro Medicus’s previous Interim dividend of $0.18. Pro Medicus’s payout ratio is currently 56.41%.
About Pro Medicus
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.
See Also
- Five stocks we like better than Pro Medicus
- How to Use the MarketBeat Excel Dividend Calculator
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Investing in Travel Stocks Benefits
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.